Publications

  1. Driver-Dunckley ED, Adler CH. Movement disorders and sleep. Neurol Clin. 2012 Nov; 30(4):1345-58. 2279659
    View PubMed
  2. Noe KH, Grade M, Stonnington CM, Driver-Dunckley E, Locke DE. Confirming psychogenic nonepileptic seizures with video-EEG: sex matters. Epilepsy Behav. 2012 Mar; 23(3):220-3. Epub 2012 Feb 15. 2226458
    View PubMed
  3. *Shneyder N, Lyons MK, Driver-Dunckley E, Evidente VG. Cerebellar Ataxia from Multiple Potential Causes: Hypothyroidism, Hashimoto's Thyroiditis, Thalamic Stimulation, and Essential Tremor. Tremor Other Hyperkinet Mov (N Y). 2012; 2 Epub 2012 Mar 22. 2306760
    View PubMed
  4. *Damian A, Adler CH, Hentz JG, Shill HA, Caviness JN, Sabbagh MN, Evidente VGH, Beach TG, Driver-Dunckley E. Autonomic function, as self-reported on the SCOPA-autonomic questionnaire, is normal in essential tremor but not in Parkinson's disease. Parkinsonism Relat Disord. 2012; 18(10):1089-93. 2293282
  5. Caviness JN, Adler CH, Hentz JG, Shill HA, Evidente VG, Driver-Dunckley ED, Sabbagh MN, Sue L, Beach TG. Incidental Lewy body disease: electrophysiological findings suggesting pre-clinical Lewy body disorders. Clin Neurophysiol. 2011 Dec; 122(12):2426-32. Epub 2011 May 26. 2166908
    View PubMed
  6. Evidente VG, Premkumar AP, Adler CH, Caviness JN, Driver-Dunckley E, Lyons MK. Medication dose reductions after pallidal versus subthalamic stimulation in patients with Parkinson's disease. Acta Neurol Scand. 2011 Sep; 124(3):211-4. Epub 2010 Oct 25. 2121263
    View PubMed
  7. Klassen BT, Hentz JG, Shill HA, Driver-Dunckley E, Evidente VG, Sabbagh MN, Adler CH, Caviness JN. Quantitative EEG as a predictive biomarker for Parkinson disease dementia. Neurology. 2011 Jul 12; 77(2):118-24. Epub 2011 Jun 01. 2167787
    View PubMed
  8. Adler CH, Hentz JG, Shill HA, Sabbagh MN, Driver-Dunckley E, Evidente VG, Jacobson SA, Beach TG, Boeve B, Caviness JN. Probable RBD is increased in Parkinson's disease but not in essential tremor or restless legs syndrome. Parkinsonism Relat Disord. 2011 Jul; 17(6):456-8. Epub 2011 Apr 08. 2157508
    View PubMed
  9. Caviness JN, Lue LF, Beach TG, Hentz JG, Adler CH, Sue L, Sadeghi R, Driver-Dunckley E, Evidente VG, Sabbagh MN, Shill HA, Walker DG. Parkinson's disease, cortical dysfunction, and alpha-synuclein. Mov Disord. 2011 Jul; 26(8):1436-42. Epub 2011 May 03. 2163842
    View PubMed
  10. Driver-Dunckley E, Stonnington CM, Locke DE, Noe K. Comparison of psychogenic movement disorders and psychogenic nonepileptic seizures: is phenotype clinically important? Psychosomatics. 2011 Jul-Aug; 52(4):337-45. Epub 2011 Jun 08. 2177040
    View PubMed
  11. Papay K, Mamikonyan E, Siderowf AD, Duda JE, Lyons KE, Pahwa R, Driver-Dunckley ED, Adler CH, Weintraub D. Patient versus informant reporting of ICD symptoms in Parkinson's disease using the QUIP: validity and variability. Parkinsonism Relat Disord. 2011 Mar; 17(3):153-5. Epub 2010 Dec 24. 2151439
    View PubMed
  12. Stonnington CM, Driver-Dunckley ED, Noe KH, Locke DEC. Conversion and somatization disorders. BMJ Best Practice. 2010 accessible on epocrates.com; www.bestpractice.bmj.com. 2010 Sep. 2126806
  13. Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White Iii CL, Akiyama H, Caviness JN, Shill HA, Sabbagh MN, Walker DG, Arizona Parkinson's Disease Consortium. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol. 2010 Jun; 119(6):689-702. Epub 2010 Mar 21. 2143927
    View PubMed
  14. Driver-Dunckley ED, Hoxworth JM, Patel NP, Bosch EP, Goodman BP. Superficial siderosis mimicking amyotrophic lateral sclerosis. J Clin Neuromuscul Dis. 2010 Mar; 11(3):137-44. 1990467
    View PubMed
  15. Thaera GM, Wellik KE, Barrs DM, Dunckley ED, Wingerchuk DM, Demaerschalk BM. Are corticosteroid and antiviral treatments effective for bell palsy? A critically appraised topic. Neurologist. 2010 Mar; 16(2):138-40. 1990449
    View PubMed
  16. McKinnon J, Evidente V, Driver-Dunckley E, Premkumar A, Hentz J, Shill H, Sabbagh M, Caviness J, Connor D, Adler C. Olfaction in the elderly: a cross-sectional analysis comparing Parkinson's disease with controls and other disorders. Int J Neurosci. 2010 Jan; 120(1):36-9. 1985092
    View PubMed
  17. Driver-Dunckley E, Connor D, Hentz J, Sabbagh M, Silverberg N, Hernandez J, Vedders L, Evidente VG, Shill H, Caviness J, Adler C. No evidence for cognitive dysfunction or depression in patients with mild restless legs syndrome. Mov Disord. 2009 Sep 15; 24(12):1840-2. 1953788
    View PubMed
  18. Stonnington CM, Driver-Dunckley ED, Noe KH, Locke DEC. Conversion and somatization disorders. BMJ Best Practice. 2009 accessible on epocrates.com. Available at: www.bestpractice.bmj.com. 2009 Sep. 1966572
  19. Weintraub D, Hoops S, Shea JA, Lyons KE, Pahwa R, Driver-Dunckley ED, Adler CH, Potenza MN, Miyasaki J, Siderowf AD, Duda JE, Hurtig HI, Colcher A, Horn SS, Stern MB, Voon V. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Mov Disord. 2009 Jul 30; 24(10):1461-7. 1981949
    View PubMed
  20. Almaraz AC, Driver-Dunckley ED, Woodruff BK, Wellik KE, Caselli RJ, Demaerschalk BM, Adler CH, Caviness JN, Wingerchuk DM. Efficacy of rivastigmine for cognitive symptoms in Parkinson disease with dementia. Neurologist. 2009 Jul; 15(4):234-7. 1952577
    View PubMed
  21. Alvarez MV, Driver-Dunckley EE, Caviness JN, Adler CH, Evidente VG. Case series of painful legs and moving toes: clinical and electrophysiologic observations. Mov Disord. 2008 Oct 30; 23(14):2062-6. 1915711
    View PubMed
  22. Goodman BP, Driver-Dunckley ED, Leslie KO, Patel AC, Wesselius LJ. A case of gait unsteadiness--an atypical manifestation of an unusual disease. Lancet Neurol. 2007 Nov; 6(11):1029-32. 1853555
    View PubMed
  23. Alvarez MV, Evidente VG, Driver-Dunckley ED. Differentiating Parkinson's disease from other parkinsonian disorders. Semin Neurol. 2007 Sep; 27(4):356-62. 1841499
    View PubMed
  24. Driver-Dunckley ED, Noble BN, Hentz JG, Evidente VG, Caviness JN, Parish J, Krahn L, Adler CH. Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome. Clin Neuropharmacol. 2007 Sep-Oct; 30(5):249-55. 1844480
    View PubMed
  25. Caviness JN, Hentz JG, Evidente VG, Driver-Dunckley E, Samanta J, Mahant P, Connor DJ, Sabbagh MN, Shill HA, Adler CH. Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson's disease. Parkinsonism Relat Disord. 2007 Aug; 13(6):348-54. Epub 2007 Mar 08. 1834797
    View PubMed
  26. Caviness JN, Driver-Dunckley E, Connor DJ, Sabbagh MN, Hentz JG, Noble B, Evidente VG, Shill HA, Adler CH. Defining mild cognitive impairment in Parkinson's disease. Mov Disord. 2007 Jul 15; 22(9):1272-7. 1837036
    View PubMed
  27. Sabbagh MN, Lahti T, Connor DJ, Caviness JN, Shill H, Vedders L, Mahant P, Samanta J, Burns RS, Evidente VG, Driver-Dunckley E, Reisberg B, Bircea S, Adler CH. Functional ability correlates with cognitive impairment in Parkinson's disease and Alzheimer's disease. Dement Geriatr Cogn Disord. 2007; 24(5):327-34. Epub 2007 Sep 13. 1848862
    View PubMed
  28. Driver-Dunckley E, Evidente VG, Adler CH, Hillman R, Hernandez J, Fletcher G, Lyons MK. Restless legs syndrome in Parkinson's disease patients may improve with subthalamic stimulation. Mov Disord. 2006 Aug; 21(8):1287-9. 1779547
    View PubMed
  29. Driver-Dunckley E, Evidente VGH. Hemichorea-hemiballismus may respond to topiramate. Clin Neuropharmacol. 2005 May-Jun; 28(3):142-4. 1721479
    View PubMed
  30. Driver-Dunckley E, Samanta J, Stacy M. Pathological gambling associated with dopamine agonist therapy in Parkinson's disease. Neurology. 2003 Aug 12; 61(3):422-3. 1891394
    View PubMed
  31. Chamberlain NL, Driver ED, Miesfeld RL. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res. 1994 Aug 11; 22(15):3181-6. 1891268
    View PubMed